Price & volume screen · refreshed after the Sep 28, 2026 close
Six-month momentum leaders: Healthcare
Large companies with the strongest six-month price performance. Ranks companies worth at least $1B by their six-month split-adjusted return.
| # | Company | Price | 1M | 6M | From high | Mkt cap |
|---|---|---|---|---|---|---|
| 1 | AGLagilon healthHealthcare | $79.53 | −15.6% | +702.9% | −60.4% | $1.34B |
| 2 | TXG10x GenomicsHealthcare | $88.50 | +36.5% | +354.3% | 0.0% | $11.53B |
| 3 | ABCLAbCellera BiologicsHealthcare | $13.92 | +12.3% | +325.7% | 0.0% | $4.51B |
| 4 | TWSTTwist BioscienceHealthcare | $179.60 | +17.3% | +303.3% | −2.4% | $11.91B |
| 5 | MRNAModernaHealthcare | $197.28 | +38.2% | +298.1% | −0.8% | $78.76B |
| 6 | CDNACareDxHealthcare | $64.60 | +23.4% | +285.0% | 0.0% | $3.34B |
| 7 | IOVAIovance BiotherapeuticsHealthcare | $10.99 | +33.1% | +213.1% | −0.1% | $4.98B |
| 8 | CORTCorcept TherapeuticsHealthcare | $115.63 | −1.1% | +207.5% | −6.4% | $12.50B |
| 9 | GRALGRAILHealthcare | $132.63 | +60.8% | +173.5% | 0.0% | $5.92B |
| 10 | MRVIMaravai LifeSciences HoldingsHealthcare | $7.63 | −8.8% | +166.8% | −15.2% | $1.14B |
| 11 | SDGRSchrodingerHealthcare | $29.50 | +44.5% | +166.2% | −3.9% | $2.21B |
| 12 | SLSSELLAS Life Sciences GroupHealthcare | $11.59 | −23.8% | +165.5% | −25.0% | $2.34B |
| 13 | QUREuniQureHealthcare | $39.11 | −21.1% | +164.8% | −44.6% | $2.71B |
| 14 | PSNLPersonalisHealthcare | $16.32 | −2.9% | +157.4% | −11.2% | $1.74B |
| 15 | ETONEton PharmaceutcialsHealthcare | $59.18 | −5.6% | +154.6% | −8.1% | $1.69B |
| 16 | PLSEPulse Biosciences, Inc Common Stock (DE)Healthcare | $52.32 | +7.7% | +154.4% | −5.2% | $3.73B |
| 17 | KODKodiak SciencesHealthcare | $89.92 | +129.9% | +143.0% | 0.0% | $5.65B |
| 18 | URGNUroGen PharmaHealthcare | $40.90 | −10.1% | +138.2% | −18.7% | $2.00B |
| 19 | OGNOrganon &Healthcare | $13.73 | −0.2% | +135.1% | −0.4% | $3.61B |
| 20 | BFLYButterfly NetworkHealthcare | $9.15 | +4.9% | +133.4% | −7.9% | $2.44B |
| 21 | ILMNIlluminaHealthcare | $271.90 | +19.4% | +131.1% | −0.7% | $41.06B |
| 22 | ADPTAdaptive BiotechnologiesHealthcare | $28.51 | +7.8% | +129.7% | −3.6% | $4.55B |
| 23 | TVTXTravere TherapeuticsHealthcare | $61.57 | −8.8% | +125.9% | −8.8% | $5.80B |
| 24 | NTRANateraHealthcare | $411.77 | +21.6% | +125.4% | −0.2% | $59.35B |
| 25 | XNCRXencorHealthcare | $25.60 | −11.4% | +124.2% | −12.6% | $1.90B |
| 26 | FTREFortrea HoldingsHealthcare | $20.06 | +6.4% | +121.2% | −3.1% | $1.91B |
| 27 | AMLXAmylyx PharmaceuticalsHealthcare | $29.85 | −19.7% | +120.3% | −24.7% | $3.81B |
| 28 | RVMDRevolution MedicinesHealthcare | $201.74 | −8.8% | +118.1% | −8.8% | $43.24B |
| 29 | DFTXDefinium TherapeuticsHealthcare | $38.41 | −12.3% | +114.8% | −20.7% | $5.16B |
| 30 | PGENPrecigenHealthcare | $7.81 | +8.6% | +112.8% | −1.0% | $2.80B |
| 31 | BLFSBioLife SolutionsHealthcare | $39.15 | +5.2% | +110.6% | 0.0% | $1.92B |
| 32 | LQDALiquidiaHealthcare | $73.67 | +5.3% | +110.3% | −19.1% | $6.59B |
| 33 | GHGuardant HealthHealthcare | $177.33 | +5.2% | +109.6% | −3.2% | $23.80B |
| 34 | AVTRAvantorHealthcare | $15.29 | +4.7% | +106.3% | −3.6% | $10.34B |
| 35 | ATRCAtriCureHealthcare | $58.41 | +18.6% | +102.3% | −3.9% | $2.97B |
| 36 | HTFLHeartflowHealthcare | $49.92 | +3.8% | +102.2% | −1.6% | $4.34B |
| 37 | MBXMBX BiosciencesHealthcare | $57.54 | −13.3% | +101.9% | −18.6% | $2.77B |
| 38 | AVAHAveanna Healthcare HoldingsHealthcare | $12.69 | −8.2% | +101.7% | −11.8% | $2.77B |
| 39 | OMEROmerosHealthcare | $19.43 | +0.9% | +96.7% | −7.7% | $1.41B |
| 40 | HAEHaemoneticsHealthcare | $105.79 | +0.8% | +95.8% | −2.8% | $4.81B |
| 41 | BBNXBeta BionicsHealthcare | $20.52 | +5.0% | +90.7% | −35.9% | $1.11B |
| 42 | ORKAOruka TherapeuticsHealthcare | $84.19 | −12.8% | +89.3% | −25.5% | $5.57B |
| 43 | BRKRBrukerHealthcare | $63.28 | +6.8% | +87.7% | −1.6% | $9.64B |
| 44 | LFSTLifeStance Health GroupHealthcare | $11.84 | −3.7% | +87.3% | −11.5% | $4.50B |
| 45 | CAICaris Life SciencesHealthcare | $31.75 | +20.4% | +87.3% | −3.6% | $8.97B |
| 46 | RLAYRelay TherapeuticsHealthcare | $17.69 | −8.9% | +84.3% | −14.7% | $3.88B |
| 47 | HALOHalozyme TherapeuticsHealthcare | $112.89 | +5.6% | +83.2% | −2.0% | $12.81B |
| 48 | XERSXeris Biopharma HoldingsHealthcare | $9.83 | +14.3% | +82.0% | −0.7% | $1.79B |
| 49 | SYRESpyre TherapeuticsHealthcare | $85.79 | −8.4% | +81.3% | −21.2% | $7.56B |
| 50 | RVTYRevvityHealthcare | $151.02 | +16.4% | +80.0% | −0.1% | $16.85B |
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.